Lucio Iannone, PhD

Managing Director

---

Lucio Iannone is a healthcare investor with more than 15 years of experience spanning venture capital, board leadership, and biotechnology. Prior to joining the T1D Fund, he served as Head of Health Investments at Leaps by Bayer, where he led the global investment team, shaped investment strategy, and directed deal execution across a portfolio with more than $1 billion in assets under management.

Lucio has served on the boards of over 18 companies. His scientific and investment background includes deep expertise in molecular biology, cell and gene therapy, and therapeutic innovation across oncology, autoimmune disease, and cardiovascular health.

Lucio earned his Ph.D. in Medicine from Imperial College London and is passionate about advancing novel therapeutics and supporting the next generation of transformative healthcare companies.